TrustCore Financial Services’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

TrustCore Financial Services’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$11.1K	Hold	2,053	–	–	﹤0.01%	703
2022 Q3	$26K	Hold	2,053	–	–	﹤0.01%	571
2022 Q2	$10K	Hold	2,053	–	–	﹤0.01%	753
2022 Q1	$16K	Hold	2,053	–	–	﹤0.01%	685
2021 Q4	$21K	Hold	2,053	–	–	﹤0.01%	598
2021 Q3	$28K	Hold	2,053	–	–	﹤0.01%	582
2021 Q2	$45K	Sell	2,053 -3,940	-66%	-$87.5K	﹤0.01%	486
2021 Q1	$144K	Sell	5,993 -4,697	-44%	-$109K	0.02%	288
2020 Q4	$192K	Buy	10,690 +10,528	+6,499%	+$157K	0.02%	251
2020 Q3	$2K	Sell	162 -1,198	-88%	-$19.8K	﹤0.01%	789
2020 Q2	$33K	Hold	1,360	–	–	0.01%	447
2020 Q1	$15K	Buy	1,360 +1	+0.1%	+$19	﹤0.01%	529
2019 Q4	$36K	Hold	1,359	–	–	0.01%	428
2019 Q3	$31K	Hold	1,359	–	–	0.01%	445
2019 Q2	$42K	Buy	1,359 +161	+13%	+$3.39K	0.01%	392
2019 Q1	$20K	Hold	1,198	–	–	0.01%	436
2018 Q4	$23K	Sell	1,198 -575	-32%	-$21.5K	0.01%	208
2018 Q3	$93K	Buy	1,773 +898	+103%	+$49K	0.03%	224
2018 Q2	$38K	Hold	875	–	–	0.01%	336
2018 Q1	$32K	Hold	875	–	–	0.01%	335
2017 Q4	$17K	Buy	+875	New	+$18.8K	0.01%	420

Other funds holding GTHX

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

TrustCore Financial Services's GTHX Position: Q4 2022 in Review

TrustCore Financial Services held its G1 Therapeutics, Inc. Common Stock (GTHX) position steady in Q4 2022 at 2,053 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

TrustCore Financial Services first reported a position in GTHX in Q4 2017 and has held it in 21 quarters since. The position peaked at $192K in Q4 2020. 116 funds tracked by Wall St. Rank hold GTHX as of Q4 2022.

TrustCore Financial Services held 2,053 shares of G1 Therapeutics, Inc. Common Stock worth $11.1K as of Q4 2022.
TrustCore Financial Services left its G1 Therapeutics, Inc. Common Stock share count unchanged in Q4 2022.
G1 Therapeutics, Inc. Common Stock made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #703 holding.
TrustCore Financial Services first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2017 and has held it in 21 quarters since.
TrustCore Financial Services's G1 Therapeutics, Inc. Common Stock position peaked at $192K in Q4 2020.
116 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.